Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych CASC / OSCEPsychopharmacology — antipsychotics

Psych CASC / OSCE · Psychopharmacology — antipsychotics

Explaining antipsychotic choice and metabolic monitoring (CASC)

CASC-style communication station: shared decision on antipsychotic choice, metabolic risk, monitoring plan, and myths about addiction/strength.

communication1 min readVerification in progress

Target exams

FRANZCPMRCPsychABPNMD-DNB
On this page
Study tools

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
Parent of a 19-year-old with first-episode psychosis asks why you are not starting 'the strongest tablet', worries about weight and diabetes, and asks if the medicine is addictive.

Station instructions (candidate)

You have 7 minutes. Explain recommended antipsychotic treatment for first-episode psychosis to a concerned parent, including benefits, metabolic monitoring, and what happens if the first medicine does not help. Avoid jargon without explanation. Do not guarantee cure. Anchor explanations in effectiveness evidence and early intervention models rather than brand slogans.[1][3]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this CASC / OSCE. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References3ShowHide
  1. [1]Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia N Engl J Med, 2005.PMID 16172203
  2. [2]Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis Lancet, 2013.PMID 23810019
  3. [3]Kane JM, Robinson DG, Schooler NR, et al. Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program Am J Psychiatry, 2016.PMID 26481174
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousExplaining antidepressant start, side-effects and review plan (CASC)Psychopharmacology — antidepressantsNextExplaining antipsychotic weight gain and a monitoring plan (CASC)Psychopharmacology — metabolic syndrome and psychotropic monitoring